Core Laboratories NV reports results for the quarter ended in December - Earnings Summary

Core Laboratories

01/02/2023 23:32

* Core Laboratories NV  CLB.N  reported quarterly adjusted
earnings of 20 cents​​ per share for the quarter ended in
December. The mean expectation of nine analysts for the quarter
was for earnings of 20 cents per share.
    * Revenue rose 1.9% to $127.57 million from a year ago;
analysts
expected $130.34 million. 
    * Core Laboratories NV's reported EPS for the quarter was 14
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Core Laboratories NV shares had risen by 26.3% this
quarter.
    * The company reported quarterly net income of $6.75
million.
    * Wall Street's median 12-month price target for Core
Laboratories
NV is $21.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 7
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
1 at 11:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.20           0.20           Met
 Sep. 30 2022      0.15           0.18           Beat
 Jun. 30 2022      0.14           0.12           Missed
 Mar. 31 2022      0.09           0.08           Missed